Bastrup Israelsen S, Pottegard A, Sandholdt H, Madsbad S, et al. Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2. Diabetes Obes Metab 2021 Jan 27. doi: 10.1111/dom.14329.
PMID: 33502076